Bob Bradway, Amgen CEO (Justin Kase Conder/AP Images for Amgen)
Updated: Horizon's $28B sale to Amgen was kicked off by Sanofi's interest
Amgen plans to buy Horizon Therapeutics for about $28 billion in cash, bringing on board two blockbuster drugs to ease the hit the biotech giant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
